ENTRY       D10082                      Drug
NAME        Suvorexant (JAN/USAN);
            MK-4305;
            Belsomra (TN)
PRODUCT     BELSOMRA (Merck Sharp & Dohme LLC)
FORMULA     C23H23ClN6O2
EXACT_MASS  450.1571
MOL_WEIGHT  450.9207
CLASS       Neuropsychiatric agent
             DG03225  Orexin receptor antagonist
             DG03202  Hypnotic
            Metabolizing enzyme substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
            Transporter inhibitor
             DG01622  ABCB1 inhibitor
REMARK      Therapeutic category: 1190
            ATC code: N05CM19
            Product: D10082<JP/US>
EFFICACY    Hypnotic, Orexin receptor antagonist
  DISEASE   Insomnia [DS:H01609]
TARGET      HCRTR [HSA:3061 3062] [KO:K04238 K04239]
  PATHWAY   hsa04080(3061+3062)  Neuroactive ligand-receptor interaction
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]; CYP2C19 [HSA:1557]
INTERACTION Transporter inhibition: ABCB1 [HSA:5243]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05C HYPNOTICS AND SEDATIVES
                N05CM Other hypnotics and sedatives
                 N05CM19 Suvorexant
                  D10082  Suvorexant (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Sleep Disorder Agents
              Sleep Promoting Agents
               Suvorexant
                D10082  Suvorexant (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               119  Miscellaneous
                1190  Miscellaneous
                 D10082  Suvorexant (JAN/USAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03225  Orexin receptor antagonist
               D10082  Suvorexant
              DG03202  Hypnotic
               D10082  Suvorexant
             Metabolizing enzyme substrate
              DG01639  CYP2C19 substrate
               D10082  Suvorexant
              DG01633  CYP3A/CYP3A4 substrate
               D10082  Suvorexant
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               D10082  Suvorexant
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG03202  Hypnotic
               D10082  Suvorexant
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Orexin
                HCRTR
                 D10082  Suvorexant (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10082
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10082
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10082
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10082
             Drug transporters
              D10082
DBLINKS     CAS: 1030377-33-3
            PubChem: 163312227
            ChEBI: 82698
            PDB-CCD: SUV
ATOM        32
            1   C8x C    11.2000  -14.5600
            2   C8y C    11.2000  -15.9600
            3   C8x C    12.3900  -16.6600
            4   C8y C    13.6500  -15.9600
            5   C8y C    13.6500  -14.5600
            6   C8x C    12.3900  -13.8600
            7   X   Cl   10.0100  -16.6600
            8   N5x N    14.9800  -16.3800
            9   C8y C    15.7500  -15.2600
            10  O2x O    14.9800  -14.1400
            11  N1y N    17.1500  -15.2600
            12  C1x C    17.1500  -13.8600
            13  C1x C    18.2700  -12.9500
            14  N1y N    19.6000  -13.3000
            15  C1y C    20.2300  -14.5600
            16  C1x C    19.6000  -15.8200
            17  C1x C    18.2700  -16.1000
            18  C1a C    21.6300  -14.5600
            19  C5a C    20.7900  -12.6000
            20  O5a O    21.9800  -13.3000
            21  C8y C    20.7900  -11.2000
            22  C8x C    21.9800  -10.5000
            23  C8y C    21.9800   -9.1000
            24  C8x C    20.7900   -8.4000
            25  C8x C    19.6000   -9.1000
            26  C8y C    19.6000  -10.5000
            27  C1a C    23.1700   -8.4000
            28  N4y N    18.3147  -11.1251
            29  N5x N    17.1851  -10.3387
            30  C8x C    16.0920  -11.1727
            31  C8x C    16.5474  -12.4700
            32  N5x N    17.9219  -12.4378
BOND        36
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     2   7 1
            8     4   8 1
            9     8   9 2
            10    9  10 1
            11    5  10 1
            12    9  11 1
            13   14  15 1
            14   12  11 1
            15   15  16 1
            16   13  14 1
            17   11  17 1
            18   12  13 1
            19   16  17 1
            20   15  18 1 #Down
            21   19  20 2
            22   19  14 1
            23   19  21 1
            24   21  22 2
            25   22  23 1
            26   23  24 2
            27   24  25 1
            28   25  26 2
            29   21  26 1
            30   23  27 1
            31   26  28 1
            32   28  29 1
            33   29  30 2
            34   30  31 1
            35   31  32 2
            36   28  32 1
///
